MEDP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MEDP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-27), Medpace Holdings's current share price is $395.93. Medpace Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $6.41. Medpace Holdings's Cyclically Adjusted Price-to-FCF for today is 61.77.
The historical rank and industry rank for Medpace Holdings's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, Medpace Holdings's highest Cyclically Adjusted Price-to-FCF was 62.52. The lowest was 58.03. And the median was 61.22.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Medpace Holdings's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $4.599. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $6.41 for the trailing ten years ended in Mar. 2024.
The historical data trend for Medpace Holdings's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | - | - | - | - | 63.05 |
For the Diagnostics & Research subindustry, Medpace Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Medpace Holdings's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Medpace Holdings's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 395.93 | / | 6.41 | |
= | 61.77 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Medpace Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 4.599 | / | 129.4194 | * | 129.4194 | |
= | 4.599 |
Current CPI (Mar. 2024) = 129.4194.
Medpace Holdings Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201312 | 0.000 | 98.326 | 0.000 |
201403 | 0.306 | 99.695 | 0.397 |
201412 | 0.000 | 99.070 | 0.000 |
201503 | 0.104 | 99.621 | 0.135 |
201506 | 0.492 | 100.684 | 0.632 |
201509 | 0.735 | 100.392 | 0.948 |
201512 | 0.673 | 99.792 | 0.873 |
201603 | 0.231 | 100.470 | 0.298 |
201606 | 0.142 | 101.688 | 0.181 |
201609 | 1.064 | 101.861 | 1.352 |
201612 | 0.554 | 101.863 | 0.704 |
201703 | -0.122 | 102.862 | -0.153 |
201706 | 0.692 | 103.349 | 0.867 |
201709 | 0.932 | 104.136 | 1.158 |
201712 | 0.669 | 104.011 | 0.832 |
201803 | 0.531 | 105.290 | 0.653 |
201806 | 0.968 | 106.317 | 1.178 |
201809 | 1.339 | 106.507 | 1.627 |
201812 | 0.966 | 105.998 | 1.179 |
201903 | 0.844 | 107.251 | 1.018 |
201906 | 1.154 | 108.070 | 1.382 |
201909 | 1.536 | 108.329 | 1.835 |
201912 | 1.355 | 108.420 | 1.617 |
202003 | 1.146 | 108.902 | 1.362 |
202006 | 0.936 | 108.767 | 1.114 |
202009 | 1.353 | 109.815 | 1.595 |
202012 | 2.593 | 109.897 | 3.054 |
202103 | 1.346 | 111.754 | 1.559 |
202106 | 1.505 | 114.631 | 1.699 |
202109 | 2.037 | 115.734 | 2.278 |
202112 | 1.274 | 117.630 | 1.402 |
202203 | 1.017 | 121.301 | 1.085 |
202206 | 2.535 | 125.017 | 2.624 |
202209 | 3.141 | 125.227 | 3.246 |
202212 | 3.935 | 125.222 | 4.067 |
202303 | 2.194 | 127.348 | 2.230 |
202306 | 2.346 | 128.729 | 2.359 |
202309 | 3.327 | 129.860 | 3.316 |
202312 | 4.597 | 129.419 | 4.597 |
202403 | 4.599 | 129.419 | 4.599 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of Medpace Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Susan E Burwig | officer: Exec. VP, Operations | C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
August J. Troendle | director, 10 percent owner, officer: CEO | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Medpace Investors, Llc | 10 percent owner | 4620 WESLEY AVENUE, CINCINNATI OH 45212 |
Robert O. Kraft | director | ONE CVS DRIVE, WOONSOCKET RI 02895 |
Kevin M. Brady | officer: CFO & Treasurer | MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Stephen P Ewald | officer: General Counsel & Corp. Secy. | C/O MEDPACE HOLDINGS,INC., 5375 MEDPACE WAY, CINTINNATI OH 45227 |
Femida H. Gwadry-sridhar | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Ashley M. Keating | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Davenport Fred B Jr | director | |
Brian T Carley | director | C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Mccarthy Cornelius P. Iii | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Jesse J Geiger | officer: CFO & COO, Lab Operations | C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Tom C King | director | 5375 MEDPACE WAY, CINCINNATI OH 45227 |
Medpace Limited Partnership | 10 percent owner | EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT, CHANNEL ISLANDS Y7 GY1 3PP |
Cinven Capital Management (v) General Partner Ltd | 10 percent owner | EAST WING, TRAFALGAR COURT, LES BANQUES, ST. PETER PORT Y7 GY1 3PP |
From GuruFocus
By Business Wire Business Wire • 07-08-2022
By Business Wire Business Wire • 09-07-2021
By GuruFocus Research • 10-24-2023
By GuruFocus Research GuruFocus Editor • 09-08-2021
By Business Wire • 01-03-2024
By GuruFocus Research • 09-19-2023
By Business Wire • 09-26-2023
By GuruFocus Research GuruFocus Editor • 12-21-2021
By GuruFocus Research • 06-09-2023
By Business Wire Business Wire • 01-04-2023